Ghrelin, an endogenous ligand for the GH secretagogue receptor, is a novel
acylated peptide produced in the gastrointestinal endocrine cells as well a
s neuroendocrine cells in the hypothalamus. The Ser(3) residue of ghrelin i
s modified by n-octanoic acid, a modification necessary for hormonal activi
ty. Human medullary thyroid carcinoma is known to produce a variety of gast
rointestinal and neuroendocrine peptides. In the present study we investiga
ted ghrelin production in the thyroid gland, especially in human medullary
thyroid carcinoma. PCR amplification demonstrated prepro-ghrelin gene trans
cripts in normal human thyroid tissue and two medullary thyroid carcinoma c
ell lines (human TT cells and rat 6.23 cells), but not in a rat thyroid fol
licular cell line. TT cells showed the expression of prepro-ghrelin mRNA of
about 0.6 kb by Northern blot analysis. Furthermore, production of ghrelin
in TT cells was demonstrated by RIA and immunocytochemistry. Accumulation
of des-n-octanoyl ghrelin in the cultured medium of the cells was confirmed
. Finally, human medullary thyroid carcinoma surgical specimens showed sign
ificantly higher des-n-octanoyl ghrelin contents than normal thyroid tissue
s. In conclusion, we revealed that ghrelin was produced by the human thyroi
d parafollicular carcinoma cell line, TT cells. These findings suggest that
ghrelin is produced in the thyroid C cells as well as in medullary thyroid
carcinoma and may provide opportunities to investigate its physiological r
ole in the thyroid gland.